Immunocytokines: a review of molecules in clinical development for cancer therapy.
about
Enhancing Cancer Immunotherapy Via Activation of Innate ImmunityThe development of immunoconjugates for targeted cancer therapyImmunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor siteChallenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy.Safety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions.A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic responseAntibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.Ligand-targeted theranostic nanomedicines against cancerA Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus.Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity.A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradationTargeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression.Role of IL-2 in cancer immunotherapyLatent cytokines for targeted therapy of inflammatory disorders.Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.Delivering safer immunotherapies for cancer.Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunityLong-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment.Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γ.
P2860
Q26796313-C888EA6D-2D9F-415F-95FD-4A73AE7CF35FQ27021990-4B076069-1916-4023-A93A-0C6BF4A2D8F6Q28066935-372C92E4-9A8D-4CFC-B821-EBE563CF0A67Q33811204-5A0F2833-B372-47C7-9D05-6F10D816E697Q34791427-15AC6178-D4AF-4D5E-8410-884A9E16D4F1Q35077524-631B43FA-7B10-428B-B4B2-734449CEAE15Q35163167-17E5B6DF-0CF4-4393-8F11-C15B8CB72788Q35895637-20E9BB36-11F4-45E7-A73C-D1B00969A946Q35921799-FDA0DA92-D668-4FC7-A558-197E60BBBCD4Q36127898-98889411-AD71-4B7F-8DB2-10DBECF30E9CQ36216092-32F32568-F8D2-4F34-9ADF-1136BEFEFA7FQ36930091-E5D0CDB7-2E02-4D27-AB7D-4DDAE7A8ADF4Q37079072-7D8AC021-02A0-4186-A531-612C1B4AE969Q38167818-33EABB54-A228-4AC4-A30A-C64F812FA23AQ38587550-657C648A-B18A-4665-A613-1F167D1EBB37Q38871209-92DEF720-BEC3-42B2-8271-3EB6213FF4B2Q39330984-1BBADBB7-8C06-49C8-B11A-E2025B947C72Q42810456-D2019914-A225-40C5-A1EC-707D66988788Q43245438-E132E3F0-B855-4761-ABAD-47AEB4D9AD63Q47221234-5CF8B609-C3B3-49E1-807F-894C2DB0EB1AQ47277628-45F32FDF-3416-45DE-BF3B-1B3B094332B7Q50538951-6B4F6E44-40F9-4897-B3E2-482A48D1326EQ50885364-173B9EAA-5C6E-4E93-BC79-BB17D4C74B0FQ52597562-70D98281-E2AD-4F4F-9F38-308F4010AD6F
P2860
Immunocytokines: a review of molecules in clinical development for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunocytokines: a review of molecules in clinical development for cancer therapy.
@en
type
label
Immunocytokines: a review of molecules in clinical development for cancer therapy.
@en
prefLabel
Immunocytokines: a review of molecules in clinical development for cancer therapy.
@en
P2860
P356
P1476
Immunocytokines: a review of molecules in clinical development for cancer therapy.
@en
P2093
Thomas List
P2860
P356
10.2147/CPAA.S49231
P407
P50
P577
2013-08-20T00:00:00Z